8/8 In sum, we mapped the landscape of new-onset autoantibodies after COVID-19, revealing leads for further research to understand whether this is clinically important. Huge thanks to our participants, the Swedish Research Council, and the incredible team behind this work!
Thrilled to announce that our paper, Prevalent and Persistent New-Onset Autoantibodies in Mild to Severe COVID-19, is now published in @NatureComms!
https://t.co/gLkrCjkqNc
Here's a breakdown of the findings:
7/8 One antigen is suggestive of epitope spreading from anti-Spike to anti-TPO IgG, which has been linked to new thyroid disease following COVID-19, again showing the importance of preventing severe disease through vaccination.
6/8 Using epitope mapping, we validated five autoantibodies in an independent cohort and found that three of the antigens were similar to the Spike protein, hinting towards molecular mimicry.
5/8 In line with previous research, vaccination did not increase levels of most autoantibodies. However, one autoantibody rose after both infection and vaccination, though its clinical relevance remains unclear.
4/8 Three autoantibodies were linked to neuropsychiatric symptoms lasting 2+ months, reinforcing the importance of preventing severe COVID-19 through vaccination.
3/8 Most of the new-onset autoantibodies appeared in single individuals, likely due to unspecific binding. However, 22 were found in 1-10% of participants, especially in those with severe illness.
1/8 Using protein fragment arrays, we tracked the emergence of antibodies against a broad range of antigens in 525 healthcare workers and hospitalized patients with COVID-19 during 2020-2021.
2/8 While we knew infection triggers autoantibody production, we were surprised to find 60% of the detected autoantibodies persisted for 12 months. Thankfully, most of these were likely harmless.
One week ago I successfully defended my doctoral thesis On the analysis of antibody repertoires. I thoroughly enjoyed discussing my research with my outstanding opponent Albert Heck @hecklab. Very excited to explore what opportunities the coming months will hold.
@hecklab @KTHuniversity I thoroughly enjoyed our discussion which I think highlighted several opportunities for collaborations that would be very interesting to pursue. It was truly an honor having you as my opponent. Looking forward to future interactions.